Martingale Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.03M Buy
51,039
+8,809
+21% +$572K 0.08% 258
2025
Q4
$2.61M Buy
42,230
+5,089
+14% +$311K 0.07% 262
2025
Q3
$2.32M Buy
37,141
+339
+0.9% +$23.6K 0.06% 279
2025
Q2
$2.94M Sell
36,802
-100
-0.3% -$8.36K 0.07% 220
2025
Q1
$3.17M Sell
36,902
-80
-0.2% -$6.56K 0.08% 197
2024
Q4
$2.89M Buy
36,982
+11
+0% +$854 0.07% 218
2024
Q3
$2.67M Buy
36,971
+140
+0.4% +$9.91K 0.06% 246
2024
Q2
$2.54M Sell
36,831
-6
-0% -$406 0.05% 239
2024
Q1
$2.67M Buy
36,837
+800
+2% +$53.5K 0.05% 229
2023
Q4
$2.21M Sell
36,037
-1,853
-5% -$110K 0.05% 264
2023
Q3
$2.17M Sell
37,890
-300
-0.8% -$18.1K 0.05% 247
2023
Q2
$2.27M Sell
38,190
-6,910
-15% -$414K 0.04% 248
2023
Q1
$2.82M Sell
45,100
-19,245
-30% -$1.2M 0.05% 207
2022
Q4
$4.03M Buy
64,345
+7
+0% +$401 0.08% 178
2022
Q3
$3.21M Buy
64,338
+3,232
+5% +$179K 0.06% 191
2022
Q2
$3.59M Buy
61,106
+781
+1% +$43.1K 0.07% 196
2022
Q1
$3.19M Sell
60,325
-2,000
-3% -$115K 0.05% 208
2021
Q4
$3.78M Sell
62,325
-5,960
-9% -$354K 0.05% 204
2021
Q3
$3.83M Buy
68,285
+37,730
+123% +$2.07M 0.05% 200
2021
Q2
$1.59M Sell
30,555
-20,200
-40% -$970K 0.02% 294
2021
Q1
$2.24M Buy
50,755
+701
+1% +$29.5K 0.03% 253
2020
Q4
$1.75M Sell
50,054
-88,806
-64% -$3.15M 0.02% 311
2020
Q3
$5.06M Sell
138,860
-104,198
-43% -$3.87M 0.06% 219
2020
Q2
$9.13M Buy
243,058
+100
+0% +$4K 0.11% 191
2020
Q1
$8.91M Buy
242,958
+59,903
+33% +$2.33M 0.12% 184
2019
Q4
$7.42M Buy
183,055
+133,046
+266% +$4.96M 0.08% 284
2019
Q3
$1.74M Buy
+50,009
New +$1.65M 0.02% 627
2018
Q1
Sell
-50,617
Closed -$2.25M 972
2017
Q4
$2.25M Sell
50,617
-29,007
-36% -$1.32M 0.03% 504
2017
Q3
$3.99M Buy
79,624
+16,604
+26% +$848K 0.05% 369
2017
Q2
$3.33M Hold
63,020
0.05% 404
2017
Q1
$3.5M Buy
63,020
+20
+0% +$1.1K 0.05% 384
2016
Q4
$3.28M Sell
63,000
-34,410
-35% -$1.66M 0.05% 428
2016
Q3
$4.7M Buy
97,410
+77,555
+391% +$3.92M 0.07% 290
2016
Q2
$1.1M Sell
19,855
-2,020
-9% -$111K 0.02% 470
2016
Q1
$1.17M Sell
21,875
-567
-3% -$27.9K 0.02% 447
2015
Q4
$1.16M Sell
22,442
-984
-4% -$48.9K 0.03% 438
2015
Q3
$1.06M Sell
23,426
-1,199
-5% -$56.6K 0.03% 460
2015
Q2
$1.14M Buy
24,625
+13,157
+115% +$576K 0.03% 478
2015
Q1
$492K Sell
11,468
-208
-2% -$7.93K 0.01% 710
2014
Q4
$406K Sell
11,676
-15,656
-57% -$520K 0.01% 736
2014
Q3
$885K Buy
27,332
+5
+0% +$167 0.03% 533
2014
Q2
$927K Sell
27,327
-6,398
-19% -$205K 0.03% 539
2014
Q1
$920K Sell
33,725
-8,709
-21% -$259K 0.03% 523
2013
Q4
$1.52M Sell
42,434
-27,603
-39% -$917K 0.05% 392
2013
Q3
$2.11M Sell
70,037
-3,900
-5% -$128K 0.08% 291
2013
Q2
$2.15M Buy
+73,937
New +$2.08M 0.08% 280

Other funds holding PBH

Martingale Asset Management's PBH Position: Q1 2026 in Review

Martingale Asset Management increased its Prestige Consumer Healthcare (PBH) stake by 21% in Q1 2026, buying an estimated $572K and bringing the position to 51,039 shares worth $3.03M. The position accounts for 0.08% of the portfolio, ranked #258.

Martingale Asset Management first reported a position in PBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.13M in Q2 2020. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Martingale Asset Management held 51,039 shares of Prestige Consumer Healthcare worth $3.03M as of Q1 2026.
  • Martingale Asset Management bought 8,809 Prestige Consumer Healthcare shares in Q1 2026, an estimated $572K.
  • Prestige Consumer Healthcare made up 0.08% of Martingale Asset Management's portfolio in Q1 2026, its #258 holding.
  • Martingale Asset Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 46 quarters since.
  • Martingale Asset Management's Prestige Consumer Healthcare position peaked at $9.13M in Q2 2020.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.